This metabolite includes a PDE selectivity profile comparable to sildenafil and an in vitro potency for PDE5 roughly fifty% with the parent drug. Plasma concentrations of the metabolite are close to forty% of All those observed for sildenafil, so that the metabolite accounts for around twenty% of sildenafil's pharmacologic results.Persons with “c